We are live on
!
Find out more
CCM
Cadian Capital Management Portfolio holdings
AUM
$821M
1-Year Est. Return
14.36%
This Fund
S&P 500
This Quarter
Est. Return
+26.91%
1 Year Est. Return
-14.36%
3 Year Est. Return
+4.6%
5 Year Est. Return
+8.64%
10 Year Est. Return
+282.79%
AUM
$2.56B
AUM Growth
+$415M
(+19%)
Cap. Flow
-$122M
Cap. Flow
% of AUM
-4.75%
Top 10 Holdings %
Top 10 Hldgs %
68.92%
Holding
36
New
7
Increased
8
Reduced
16
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$217M |
| 2 |
AABA
Altaba Inc
AABA
|
+$69.1M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$42.3M |
| 4 |
Pegasystems
PEGA
|
+$34.7M |
| 5 |
DATA
Tableau Software, Inc.
DATA
|
+$32.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$87.2M |
| 2 |
NBIS
Nebius Group N.V.
NBIS
|
+$76.5M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$71.8M |
| 4 |
ZEN
ZENDESK INC
ZEN
|
+$68M |
| 5 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$65.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.66% |
| 2 | Communication Services | 33.08% |
| 3 | Healthcare | 7.86% |
| 4 | Industrials | 4.11% |
| 5 | Consumer Discretionary | 3.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
26
DELISTED
Blueprint Medicines
BPMC
| $16M | 0.62% |
+200,000
| New | +$14.8M |
|
|
NSTG
27
DELISTED
NanoString Technologies, Inc.
NSTG
| $13.5M | 0.53% |
565,000
-1,729,046
| -75% | -$39.7M |
|
|
EBIX
28
DELISTED
Ebix Inc
EBIX
| $8.84M | 0.35% |
179,100
| – | – |
|
|
AXDX
29
DELISTED
Accelerate Diagnostics
AXDX
| $6.26M | 0.24% |
+29,799
| New | +$5.59M |
|
|
LSXMK
30
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $3.38M | 0.13% |
116,142
-369,648
| -76% | -$11.2M |
|
|
FOLD
31
DELISTED
Amicus Therapeutics
FOLD
| $2.72M | 0.11% |
+200,000
| New | +$2.44M |
|
|
GTT
32
DELISTED
GTT Communications, Inc.
GTT
| $701K | 0.03% |
20,200
-74,800
| -79% | -$2.2M |
|
33
Incyte
INCY
$24.4B
| – | – |
-118,016
| Closed | -$7.5M |
|
34
Jazz Pharmaceuticals
JAZZ
$16.7B
| – | – |
-100,000
| Closed | -$12.4M |
|
|
ZEN
35
DELISTED
ZENDESK INC
ZEN
| – | – |
-1,165,601
| Closed | -$68M |
|
|
FDC
36
DELISTED
First Data Corporation
FDC
| – | – |
-650,000
| Closed | -$11M |
|
Similar funds
AC
DI
VT
ACM
MA
BC
SCM
FPCP
Cadian Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Cadian Capital Management held 36 positions worth $2.56B, up 19% from $2.15B the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Cadian Capital Management withdrew a net $122M in Q1 2019, closing 4 positions and reducing 16 holdings. Its most notable exit was ZENDESK INC, an estimated $68M position sold in full.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 39% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Cadian Capital Management opened a new position in Netflix worth $31.4M.
- Cadian Capital Management's largest Q1 2019 buy was Netflix: 880,000 shares worth $31.4M.
- Cadian Capital Management added most to People Inc in Q1 2019, an estimated $217M increase.
- Cadian Capital Management's biggest Q1 2019 reduction was Alphabet (Google) Class A, cutting an estimated $87.2M.
- Cadian Capital Management fully exited ZENDESK INC in Q1 2019, selling an estimated $68M.
- Cadian Capital Management's ten largest holdings make up 69% of its $2.56B portfolio in Q1 2019.
- Cadian Capital Management opened 7 new positions and closed 4 in Q1 2019.
- Cadian Capital Management's portfolio value rose 19% quarter-over-quarter to $2.56B.
Based on Cadian Capital Management's 13F filing for Q1 2019, filed 14 May 2019.